Form 4: Marcus Corp Director Receives Restricted Stock Grant
Insider Transaction Report
Marcus Corp Director Timothy E. Hoeksema reported the acquisition of 4,174 restricted common shares and updated his beneficial ownership.
Summary
- Director Timothy E. Hoeksema acquired 4,174 shares of Marcus Corp Common Stock on December 31, 2025, as a restricted stock grant with a transaction price of $0.
- The restricted stock vests 50% after the second anniversary and 100% after the fourth anniversary of the grant date.
- Following this transaction, Mr. Hoeksema directly beneficially owns 49,165 shares of Common Stock.
- Additionally, 15,002 shares are indirectly beneficially owned by the Timothy and Janis Hoeksema Revocable Trust U/A Dated 01/04/2010.
- Mr. Hoeksema also holds several stock options (Right to Buy) with exercise prices ranging from $14.25 to $38.51 and expiration dates between December 2026 and December 2033, granted under The Marcus Corporation 2004 Equity and Incentive Awards Plan.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of an insider transaction (restricted stock grant) and does not contain information that would significantly alter the company's outlook or financial position. It is a neutral event.
Positives
- Director Timothy E. Hoeksema received a grant of 4,174 restricted shares, aligning his interests with long-term shareholder value.
Negatives
- No specific negative information is disclosed in this routine insider transaction report.
Future Outlook
The restricted stock granted on December 31, 2025, is scheduled to vest 50% after its second anniversary and 100% after its fourth anniversary, indicating future equity ownership milestones for the director.
Industry Context
This filing represents a routine insider transaction, common across all industries, where directors receive equity compensation as part of their remuneration package, aligning their long-term interests with the company's performance.
Stakeholder Impact
- Shareholders: Minor positive impact as director's interests are further aligned with long-term company performance through equity ownership.
Next Steps
- Vesting of 50% of the restricted stock after December 31, 2027 (2nd anniversary).
- Vesting of the remaining 50% (total 100%) of the restricted stock after December 31, 2029 (4th anniversary).
Key Dates
| Date | Description |
|---|---|
| 01/04/2010 | Date of the Timothy and Janis Hoeksema Revocable Trust U/A. |
| 12/29/2016 | Date exercisable for 1,000 stock options with an exercise price of $31.55. |
| 12/28/2017 | Date exercisable for 1,000 stock options with an exercise price of $27.20. |
| 12/27/2018 | Date exercisable for 1,000 stock options with an exercise price of $38.51. |
| 12/26/2019 | Date exercisable for 1,000 stock options with an exercise price of $32.60. |
| 12/30/2021 | Date exercisable for 750 stock options with an exercise price of $17.95. |
| 12/29/2022 | Date exercisable for 1,438 stock options with an exercise price of $14.25. |
| 12/28/2023 | Date exercisable for 1,455 stock options with an exercise price of $14.69. |
| 12/31/2025 | Date of restricted stock grant and earliest transaction date. |
| 01/05/2026 | Signature date of the reporting person's attorney-in-fact. |
| 12/29/2026 | Expiration date for 1,000 stock options with an exercise price of $31.55. |
| 12/28/2027 | Expiration date for 1,000 stock options with an exercise price of $27.20. |
| 12/27/2028 | Expiration date for 1,000 stock options with an exercise price of $38.51. |
| 12/26/2029 | Expiration date for 1,000 stock options with an exercise price of $32.60. |
| 12/30/2031 | Expiration date for 750 stock options with an exercise price of $17.95. |
| 12/29/2032 | Expiration date for 1,438 stock options with an exercise price of $14.25. |
| 12/28/2033 | Expiration date for 1,455 stock options with an exercise price of $14.69. |
Keywords
Marcus Corp, MCS, Insider Transaction, Form 4, Restricted Stock, Director Compensation, Equity Grant, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.